InvestorsHub Logo
Followers 84
Posts 12467
Boards Moderated 0
Alias Born 07/25/2008

Re: None

Wednesday, 06/23/2010 10:16:58 PM

Wednesday, June 23, 2010 10:16:58 PM

Post# of 80490
Is this the Ariad scam?


Pfizer's Crizotinib in ALK-NSCLC; Response Rate "Unprecedented"

see for yourselves:

http://www.medscape.com/viewarticle/723075

Yet, Ariad's claim is that THEIR ALK is much more effective..

Needless to say, this feels Enron-ish to me...

Don, please sort this out!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.